Results 221 to 230 of about 260,746 (260)
Some of the next articles are maybe not open access.
Why is LDL‐cholesterol bad cholesterol?
Lipid Technology, 2008AbstractThe high circulating LDL‐cholesterol levels seen in the inherited disease familial hypercholesterolaemia cause high rates of cardiovascular disease whereas the low circulating LDL‐cholesterol levels following statin treatment cause low rates of cardiovascular disease.
openaire +1 more source
Atherosclerosis, 1987
A significant increase of LDL-apolipoprotein B by 13% and LDL-cholesterol by 19% was observed in a group of 9 patients with hyperlipoproteinaemia Type III after bezafibrate treatment. Additional administration of colestipol caused a significant decrease of both LDL-apolipoprotein B by 18% and LDL-cholesterol by 25%.
L, Kłosiewicz-Latoszek +3 more
openaire +2 more sources
A significant increase of LDL-apolipoprotein B by 13% and LDL-cholesterol by 19% was observed in a group of 9 patients with hyperlipoproteinaemia Type III after bezafibrate treatment. Additional administration of colestipol caused a significant decrease of both LDL-apolipoprotein B by 18% and LDL-cholesterol by 25%.
L, Kłosiewicz-Latoszek +3 more
openaire +2 more sources
Relationships between lymphocyte cholesterol homeostasis and LDL-cholesterol
Clinical Biochemistry, 1987The homeostasis of cholesterol was studied in lymphocytes freshly isolated from the blood and cultured with or without low-density lipoprotein (LDL). The content of cholesterol decreased in the lymphocytes cultured without LDL, whereas LDL substituted for cellular cholesterol losses, in spite of almost suppressed LDL-receptor and lymphocyte cholesterol
R, Hambitzer, I, Melzner, O, Haferkamp
openaire +2 more sources
Statins and LDL‐cholesterol lowering: an overview
Current Medical Research and Opinion, 2005Statins have become a cornerstone of treatment for dyslipidaemia primarily due to their marked lowering of low-density lipoprotein cholesterol (LDL-C). Studies show that statin treatment typically reduces relative risk of cardiovascular disease by 24-37%, regardless of age, sex, prior history of coronary heart disease (CHD), or other co-morbid ...
openaire +2 more sources
LDL cholesterol and troglitazone therapy
Diabetes Care, 1998B V, Howard, W J, Howard
openaire +2 more sources
LDL-cholesterol, HDL-cholesterol or triglycerides—which is the culprit?
Diabetes Research and Clinical Practice, 2003Dyslipidaemia in patients with type 2 diabetes commonly consists of elevated triglyceride levels; normal or slightly elevated low-density lipoprotein (LDL)-cholesterol levels with a preponderance of small, dense LDL particles; and low high-density lipoprotein (HDL)-cholesterol levels with a preponderance of small, dense HDL.
openaire +2 more sources

